Category Archives: Myocardial Infarction

A leading research firm, Zion Market Research added a latest industry report on "Global Myocardial Infarction Treatment Market" consisting of 110+ pages during the forecast period and Myocardial Infarction Treatment Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Myocardial Infarction Treatment Market. According to the report the Myocardial Infarction Treatment Market to Witness Comprehensive Growth By 2024 The Myocardial Infarction Treatment Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. The report covers the global Myocardial Infarction Treatment Market performance in terms of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global consumer electronics market.This report studies the global Myocardial Infarction Treatment Market size, industry status and forecast, competition landscape and growth opportunity Continue reading →

BACKGROUND: Survival benefit of revascularization over medical therapy (MT) in patients with stable ischemic heart disease (SIHD) is uncertain. We evaluated the prognostic effects of revascularization in patients with SIHD undergoing single-photon emission computed tomographymyocardialperfusion imaging (SPECT-MPI) Continue reading →

This article was originally published here Cardiometabolic disease costs associated with suboptimal diet in the United States: A cost analysis based on a microsimulation model. PLoS Med. Continue reading →

The Food and Drug Administration (FDA) has approved the use of Vascepa (icosapent ethyl; Amarin Pharma) as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (150mg/dL) and established CV disease or diabetes mellitus and 2 or more additional risk factors for CV disease. The approval was based on data from the phase 3 REDUCE-IT trial that assessed the CV outcomes of 8179 patients who were administered Vascepa as an add-on to statins, and who had elevated TG levels (135mg/dL) with either CV disease or diabetes and other CV risk factors. The primary composite end point included time to first occurrence of CV death, myocardial infarction, stroke, coronary revascularization, or hospitalization for unstable angina (5-point major adverse cardiovascular event [MACE]) Continue reading →

Questions about age and health have dogged Biden on the campaign trail. He is one of four candidates in their 70s; another is Bernie Sanders, who recently suffered a heart attack Continue reading →

Walking and cycling to work were associated with fewer heart attacks across 43 million adults in England, according to a new national study. Co-authored by Alistair and Jonny Brownlee, Olympic-medal winning triathletes and alumni of the University of Leeds, the research suggests that active travel could provide important health benefits Continue reading →

AIMS: PEGASUS-TIMI 54 demonstrated that long-term dual antiplatelet therapy (DAPT) with aspirin and ticagrelor reduced the risk of major adverse cardiovascular events (MACE), with an acceptable increase in bleeding, in patients with priormyocardial infarction(MI). While much of the discussion around prolonged DAPT has been focused on stented patients, patients with prior MI without prior coronary stenting comprise a clinically important subgroup. Continue reading →

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (Takeda), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that underscore its commitment to advancing treatments for rare bleeding disorders by incorporating real-world data and developing innovative adeno-associated virus (AAV) gene therapies. Continue reading →

Getty Juice WRLD had a heart attack, Chicago fire says. Juice WRLD, the talented Chicago-born rapper whose Lucid Dreams was a massive hit, died from cardiac arrest, Heavy has confirmed with that Chicago Fire Department. However, what caused him to go into cardiac arrest is not clear Continue reading →

The Myocardial Infarction Instrument market report considers the present scenario of the Myocardial Infarction Instrument market and its market dynamics for the period 20192024. It covers a detailed overview of various market growth enablers, restraints, and trends. The study includes both the demand and supply sides of the market. Continue reading →